BSX icon

Boston Scientific
BSX

Overview Fund Activity

785 hedge funds and large institutions have $49B invested in Boston Scientific in 2019 Q1 according to their latest regulatory filings, with 115 funds opening new positions, 301 increasing their positions, 245 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
785
Holders Change
+58
Holders Change %
+7.98%
% of All Funds
17.02%
Holding in Top 10
15
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-25%
% of All Funds
0.33%
New
115
Increased
301
Reduced
245
Closed
51
Calls
$143M
Puts
$64.6M
Net Calls
+$78M
Net Calls Change
-$12M

Top Buyers

1
TP
1
Third Point
New York
$192M
2
A
2
AustralianSuper
Australia
$177M
3
Bessemer Group
3
Bessemer Group
New Jersey
$163M
4
Massachusetts Financial Services
4
Massachusetts Financial Services
Massachusetts
$437M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$169M

Top Sellers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$245M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$2.11B
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.63B
4
FAM
4
Fred Alger Management
New York
$385M
5
Citadel Advisors
5
Citadel Advisors
Florida
$33.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
Legal & General Group
26
Legal & General Group
United Kingdom
$329M +$60.2M +1,567,394 +22%
Aberdeen Group
27
Aberdeen Group
United Kingdom
$296M -$61.5M -1,601,460 -17%
AllianceBernstein
28
AllianceBernstein
Tennessee
$272M -$22.2M -579,444 -8%
Morgan Stanley
29
Morgan Stanley
New York
$264M -$30.4M -791,002 -10%
TCIM
30
TIAA CREF Investment Management
New York
$263M +$24.6M +640,207 +10%
VOYA Investment Management
31
VOYA Investment Management
Georgia
$252M -$2.46M -64,195 -1%
Deutsche Bank
32
Deutsche Bank
Germany
$247M +$116M +3,015,719 +88%
Capital Research Global Investors
33
Capital Research Global Investors
California
$245M -$384M -10,015,149 -61%
DZ Bank
34
DZ Bank
Germany
$225M +$116M +3,028,077 +107%
O
35
OrbiMed
New York
$222M – – –
O
36
OppenheimerFunds
New York
$217M -$17.7M -462,003 -8%
Charles Schwab
37
Charles Schwab
California
$212M +$3.12M +81,194 +1%
Neuberger Berman Group
38
Neuberger Berman Group
New York
$209M -$18.8M -490,866 -8%
Sumitomo Mitsui Trust Group
39
Sumitomo Mitsui Trust Group
Japan
$207M -$2.11M -54,997 -1%
Swiss National Bank
40
Swiss National Bank
Switzerland
$199M +$438K +11,400 +0.2%
PI
41
Putnam Investments
Massachusetts
$193M -$7.57M -197,334 -4%
SIG
42
Senator Investment Group
New York
$192M -$19.2M -500,000 -9%
TP
43
Third Point
New York
$192M +$192M +5,000,000 New
Millennium Management
44
Millennium Management
New York
$179M -$824K -21,458 -0.5%
A
45
AustralianSuper
Australia
$177M +$177M +4,620,692 New
EIP
46
Epoch Investment Partners
New York
$170M -$5.6M -146,035 -3%
Marshall Wace
47
Marshall Wace
United Kingdom
$169M +$121M +3,158,088 +251%
American Century Companies
48
American Century Companies
Missouri
$169M +$10.2M +265,691 +6%
UBS AM
49
UBS AM
Illinois
$165M +$145K +3,789 +0.1%
Bessemer Group
50
Bessemer Group
New Jersey
$163M +$163M +4,244,722 +105,695%
1
2
3 4 5